Melaleuca teamed with Dr. William Diehl-Jones of the University of Manitoba, a respected researcher known for developing the most advanced, lifelike model for studying pharmaceutical and nutritional bioavailability.
Together with Melaleuca senior scientist Dr. Alexander Rabovsky, Dr. Diehl-Jones designed a study that used live human intestinal cells to recreate the mechanism of absorption in the human digestive tract.
For the first time ever, a complete multivitamin-mineral formula was tested for absorption using actual human intestinal cells.
The absorption study clearly demonstrated that Oligo not only delivers a striking level of solubility, but also delivers an unmatched level of absorption through the intestinal wall.
Even more profound were the results from the groundbreaking study with Dr. Bruno Fink—a specialist in the measurement of free radical activity in the human body. Dr. Fink is the founder of Noxygen Science Transfer and Diagnostics, a top research institution located in Elzach, Germany.
The purpose was to measure—in a live body—the difference in free radical activity after two different vitamin formulations were digested. One contained Oligo minerals. The other: non-Oligo mineral forms used in major brands.
The study produced visual evidence of a dramatic spike in free radical activity in the digestive tract after taking the non-Oligo multivitamin-mineral supplement. The study further proved that these free radicals form in the digestive tract and then dangerously spread throughout the entire body.
More importantly, the study proved that the levels of free radicals generated by vitamin supplements containing Oligo minerals were significantly lower than formulas based on non-Oligo mineral forms.
The Noxygen free radical study proved that Oligo not only protects against dangerous free radical activity in the digestive tract, but extends that protection throughout the entire body—better than any non-Oligo mineral form on the market.